Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical firms, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to perform so might be grounds for compensation. Our lawyers are functioning hard to have these hurt by the drug the compensation they're entitled to.<br><br> <br><br> Although bleeding is a frequent complication related with anticoagulants, it has been alleged that Xarelto is much more hazardous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, in the occasion of an emergency, sufferers could be at threat for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging.<br><br> <br><br> In the event http://xareltoattorneys.bitbucket.org - http://xareltoattorneys.bitbucket.org/categories/Illinois/Xarelto-Lawsuit-Settlement-Marseilles-IL-61341.html you or a loved one particular suffered a significant bleeding event following taking Xarelto, you may have legal recourse. For much more information, make contact with us right now to have your case reviewed, free of charge of charge.<br><br> Compensation Possibilities<br><br> <br><br> xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, pain and suffering and, in circumstances of death, funeral expenses. Moreover, they may be in search of punitive damages, which are normally awarded to punish the defendant and deter other organizations from acting similarly.<br><br> Why Are Lawsuits Becoming Filed?<br><br> <br><br> Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging - http://www.automotivedigitalmarketing.com/main/search/search?q=alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Since of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.<br><br> <br><br> In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:<br><br> <br><br> The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.<br><br> The makers of the drug continue to market Xarelto as a secure anticoagulant option.<br><br> Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the event of a bleeding complication.<br><br> Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.<br><br> Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness - http://search.Usa.gov/search?affiliate=usagov&query=effectiveness in preventing hazardous clotting.<br><br> <br><br> Visit this page for more details on the alleged health risks of Xarelto.<br><br> Multidistrict Litigation Trial Dates Set<br><br> <br><br> The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.